MedPath

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

๐Ÿ‡ต๐Ÿ‡ฐPakistan
Ownership
-
Employees
-
Market Cap
-
Website

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals

Not Applicable
Completed
Conditions
HIV Infection
HIV Infections
Interventions
Behavioral: Adherence report
First Posted Date
2009-03-27
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
156
Registration Number
NCT00870792
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Tufts Medical Center, Boston, Massachusetts, United States

Psychology of Reward and Punishment: Functional and Molecular Brain Imaging and Monoaminergic Correlates

Withdrawn
Conditions
Cocaine Abuse
Cocaine Addiction
First Posted Date
2009-03-19
Last Posted Date
2017-07-02
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Registration Number
NCT00865332
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users

Phase 3
Completed
Conditions
Hepatitis C Infection
HIV Infection
Hepatitis B Infection
Interventions
Biological: hepatitis B vaccine 3 dose schedule (0,1,2 month)
Behavioral: HBV Vaccination Self-Efficacy Intervention
First Posted Date
2009-02-11
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
1260
Registration Number
NCT00841477
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas-HSC at Houston, School of Public Health, Houston, Texas, United States

A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control

Completed
Conditions
Tobacco Use Disorder
Nicotine Dependence
First Posted Date
2009-01-28
Last Posted Date
2018-07-05
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
61
Registration Number
NCT00830739
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore, Maryland, United States

Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population

Completed
Conditions
Stress
Drug Abuse
First Posted Date
2008-11-07
Last Posted Date
2025-05-20
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
373
Registration Number
NCT00787423
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute on Drug Abuse, Baltimore, Maryland, United States

Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients

Phase 1
Completed
Conditions
Cocaine Dependence
Cocaine-Related Disorders
Opioid-Related Disorders
Interventions
Drug: Airipiprazole
Drug: Placebo
First Posted Date
2008-10-28
Last Posted Date
2019-12-16
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
41
Registration Number
NCT00780702
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute on Drug Abuse, Baltimore, Maryland, United States

Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine

First Posted Date
2008-10-22
Last Posted Date
2017-01-16
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
66
Registration Number
NCT00777569
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univerisity of Minnesota, Minneapolis, Minnesota, United States

Buprenorphine Naltrexone-P1 A-Cocaine

Phase 1
Completed
Conditions
Cocaine-related Disorders
Interventions
First Posted Date
2008-08-13
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
8
Registration Number
NCT00733720
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Drug Dependence Research Center, San Fransisco, California, United States

Cognitive Behavioral Stress Management for HIV+ Drug Abusers

Phase 1
Completed
Conditions
HIV/AIDS
Drug Abuse
Alcohol Abuse
First Posted Date
2008-07-25
Last Posted Date
2017-01-11
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
450
Registration Number
NCT00722644

Effects of Propranolol on Responses to Drug-Related Imagery Scripts

Phase 1
Terminated
Conditions
Cocaine Dependence
Interventions
Drug: Placebo
First Posted Date
2008-06-03
Last Posted Date
2019-12-17
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Target Recruit Count
40
Registration Number
NCT00688805
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute on Drug Abuse, Baltimore, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath